PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours
Titel:
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours
Auteur:
Dillon, M.T. Boylan, Z. Smith, D. Guevara, J. Mohammed, K. Peckitt, C. Saunders, M. Banerji, U. Clack, G. Smith, S.A. Spicer, J.F. Forster, M.D. Harrington, K.J.